Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.3801
+0.0051 (1.36%)
At close: Sep 8, 2026, 4:00 PM EDT
0.3740
-0.0061 (-1.60%)
After-hours: Sep 8, 2026, 5:05 PM EDT

Xtant Medical Holdings Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Xtant Medical Holdings stock has a consensus rating of "Strong Buy" and an average price target of $1.03. The average 1-year stock price forecast is 170.98% higher than the current stock price, while the lowest is $0.60 (+57.85%) and the highest is $1.50 (+294.63%).

Price Target: $1.03 (+170.98%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$0.60$1.03$1.00$1.50
Change+57.85%+170.98%+163.09%+294.63%

Analyst Ratings

The average analyst rating for Xtant Medical Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jul '26Aug '26Sep '26
Strong Buy222112
Buy001111
Hold000000
Sell000000
Strong Sell000000
Total223223

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Lucid Capital
Lucid Capital
Buy
Initiates
$1
BuyInitiates$1+163.09%Sep 2, 2026
Maxim Group
Maxim Group
Buy
Reiterates
$0.95$1.5
BuyReiterates$0.95$1.5+294.63%Aug 28, 2026
Craig-Hallum
Craig-Hallum
Buy
Reiterates
$1.2$0.6
BuyReiterates$1.2$0.6+57.85%Aug 12, 2026
BTIG
BTIG
Buy
Maintains
$1.5$1
BuyMaintains$1.5$1+163.09%Apr 1, 2026

Financial Forecast

Revenue This Year
99.44M
from 133.93M
Decreased by -25.75%
Revenue Next Year
110.24M
from 99.44M
Increased by 10.85%
EPS This Year
-0.08
from 0.04
EPS Next Year
-0.03
from -0.08
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
55.26M57.97M91.30M117.27M133.93M99.44M
Revenue Growth
3.61%4.90%57.50%28.44%14.21%-25.75%
Gross Profit
32.49M32.14M55.47M68.22M84.27M58.94M
Gross Margin
58.79%55.44%60.75%58.17%62.92%59.27%
Operating Income
-3.25M-6.76M-10.16M-12.07M7.28M-14.45M
Net Income
-4.85M-8.49M660.00K-16.45M4.97M-16.11M
EPS
----0.04-0.08
Free Cash Flow
262.38K-4.20M-25.38M-9.47M6.50M-9.65M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High100.5M
Avg99.4M
Low97.8M

Revenue Growth

Revenue Growth202620272028
High
-24.9%
Avg
-25.7%
Low
-27.0%

EPS Forecast

EPS202620272028
High-0.08
Avg-0.08
Low-0.08

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-